Following Covid-19, the Practice has changed ways of working and how we review patients with long term conditions such as diabetes, cardiovascular disease or asthma.
From April 2022 onwards we are aiming to review patients around the time of their month of birth. There will be a transition phase as we work towards this. For example, if your month of birth is April, you will receive an invite from the Practice to attend for a Long Term Condition review in that month. Usually this will mean an appointment with a member of our nursing/healthcare team who will review your conditions.
In the first year of this process, it may mean that some patients will be getting their review shortly after already having a review, and for others there will be a slightly longer gap before their review will happen. This will even out by next year. As with any new service there may be some unforeseen problems, so please bear with us all as we adapt to it.
We are going to use more online services to help with this. You may be sent an SMS message asking you to complete an online questionnaire to help us collect important information. If you have the Airmid app you may also be able to complete questions through this app. This information helps the nurses know if you are having any particular problems ahead of any review appointment you may be asked to attend.
If you have a respiratory condition such as asthma or COPD you may be asked to make an appointment with a specialist member of the team.
Following receipt of your questionnaire and/or appointment(s), we will then review your medication. If at any time your repeat prescription has reached its review date, please request your medication in the normal way; we will review your medication remotely and only contact you if there are any queries. If you order online, please use the “custom note” box if you are having any issues with ordering.
This should streamline our Long Term Condition review process and by doing it in your month of birth we are hoping it makes it easier for you to remember when your review will be due. We hope that patients will find this more convenient.